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2Abstract
Human mesenchymal stem cells (MSCs), which can generate both osteoblasts and chondrocytes, represent an
ideal resource for orthopaedic repair using tissue engineering approaches. One major difficulty for the
development of osteochondral constructs using undifferentiated MSCs is that serum is typically used in culture
protocols to promote differentiation of the osteogenic component, whereas existing chondrogenic differentiation
protocols rely on the use of serum-free conditions. In order to define conditions which could be compatible with
both chondrogenic and osteogenic differentiation in a single bioreactor, we have analysed the efficiency of new
biphasic differentiation regimes based on transient serum exposure followed by serum-free treatment.
MSC differentiation was assessed either in serum-free medium or with a range of transient exposure to
serum, and compared to continuous serum-containing treatment. Although osteogenic differentation was not
supported in the complete absence of serum, marker expression and extensive mineralisation analyses
established that 5-day transient exposure triggered a level of differentiation comparable to that observed when
serum was present throughout. This initial phase of serum exposure was further shown to support the successful
chondrogenic differentiation of MSCs, comparable to controls maintained in serum-free conditions throughout.
This study indicates that a culture based on temporal serum exposure followed by serum-free treatment is
compatible with both osteogenic and chondrogenic differentiation of MSCs. These results will allow the
development of novel strategies for osteochondral tissue engineering approaches using MSCs for regenerative
medicine.
31. Introduction
In the natural joint, articular cartilage plays an important role protecting the subchondral bone from high
stresses, as well as reducing nominal contact pressure and allowing low-friction movements (Mow et al., 1993;
Little, 1969). Both the articular cartilage and the underlying subchondral bone are often subjected to structural
damage as a result of trauma and disease, leading to severe pain, joint deformity, loss of motion and the need for
surgical procedures (Tampieri et al., 2008; Swieszkowski et al., 2007). Due to the avascular, non-innervated
nature of cartilage, and its limited capacity to repair itself, there is an increased demand to engineer
osteochondral grafts that overcome the problems of standard chondral grafts such as donor site morbidity and
poor anchorage between the native tissue and the chondral construct (Cancedda et al., 2003). Typical
osteochondral grafts consist of a superficial cartilaginous layer and an underlying calcified tissue, representing
cartilage and bone respectively, which often delaminate when subjected to mechanical loads and stresses of the
body (Martin et al., 2007). Approaches considered for joint tissue repair include cell-free composites, eg
ceramic-based devices, and scaffolds loaded with a single cell type or with more complex multi-lineage cell
populations (Tampieri et al., 2008; Vinatier et al., 2009). Although more physiologically relevant, scaffolds
engineered to host multiple cell types are technically challenging to seed and populate homogenously. An
optimal solution would be to engineer a homogeneous scaffold using a single cell source that has both
osteogenic and chondrogenic differentiation potential, thus overcoming complications of multi-cellular and
multi-media approaches that can lead to delamination of the bone and cartilage regions, and ultimately
contribute largely to the failure of the construct.
Mesenchymal stem cells (MSCs) have been utilised in many tissue engineering applications for several
years (Caplan and Bruder., 2001), due to their ability to differentiate towards multiple lineages including
osteoblasts, chondrocytes, and adipocytes (Pittenger et al., 1999; Mackay et al., 1998; Young et al., 1998).
MSCs are the primary cell source for endochondral and intramembranous bone formation in vivo (Caplan et al.,
1987), making them an ideal resource for the production of cell-seeded osteochondral constructs that can be
utilised for bone repair. In addition, MSCs represent a potential autologous cell source, which would overcome
graft rejection issues previously seen in the repair of chondral defects (Csaki et al., 2008; Bruder et al., 1994;
Deans and Moseley., 2000), and autologous MSCs have already been successfully used in a clinical setting for
bone repair (Quarto et al., 2001). Conditions for the osteogenic and chondrogenic differentiation of MSCs have
been described for many years in the literature (Bruder et al., 1994; Bruder et al., 1997; Pittenger et al., 1999;
4Sottile et al., 2002). One key difference in the culture conditions used to stimulate osteogenic and chondrogenic
differentiation is the use of serum: osteogenic treatments typically include 10% serum, whereas chondrogenic
differentiation protocols are carried out in serum-free medium. The presence of serum, an ill-defined cocktail of
growth factors, proteins, toxin scavengers and other source-dependant substances (Liu et al., 2007), is thus
considered an unsuitable component to support the simultaneous differentiation into these two lineages.
In order to design treatment regimes which could resolve this incompatibility and provide a basis for the
differentiation of both osteogenic and chondrogenic lineages in MSC-seeded constructs cultured in a single
chamber, we investigated the use of new biphasic treatments. The research presented here examines a new
approach to MSC differentiation using culture conditions involving transient FCS exposure, and reports on the
efficacy of these new treatments for the differentiation of MSCs towards osteogenic and chondrogenic lineages.
52. Materials and methods
All reagents were purchased from Invitrogen (Paisley, UK) unless otherwise stated.
2.1. Cell culture
A culture of an human bone marrow-derived mesenchymal stem cell (hMSCs) line (Okamoto et al., 2002;
Sottile et al., 2003) was maintained in a monolayer culture in complete Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% (v/v) foetal calf serum (FCS), 1% (v/v) L-glutamine, 1% (v/v) non-essential
amino acids (NEAA) and 1% (v/v) penicillin/ streptomycin, in a humidified atmosphere at 37°C, 5% CO2. For
the purposes of the work presented here, this medium will be referred to as standard culture medium (SC).
Monolayer cultures were passaged by enzymatic digestion using 0.02% trypsin/ EDTA, producing a single cell
suspension, and cells were passaged using 1 in 4 dilutions for culture maintenance. Live cell counts carried out
using Trypan blue exclusion were used to determine the final cell seeding density of (2 x 104 cells/ ml). For
mineral deposition analysis, ThermanoxTM tissue culture plastic discs (NuncTM, Fisher Scientific, UK) (13mm
diameter) were placed into 24 well plates and sterilised under UV for an hour. Wells were washed with
phosphate buffered saline (PBS) (OXOID, UK) and 1ml of standard MSC culture medium before 1ml MSC cell
suspension was added (2 x 104 cells/ ml). Cells were allowed to attach to the ThermanoxTM discs in SC for 24
hours before starting the differentiation experiment.
2.2. Osteogenic differentiation
To evaluate different culture conditions on the osteogenic differentiation, two medium preparations were tested:
(i) OS+FCS (serum-containing osteogenic medium): DMEM supplemented with 10% (v/v) foetal calf serum
(FCS), 1% (v/v) L-glutamine, 1% (v/v) NEAA, 1% (v/v) penicillin/ streptomycin, dexamethasone (0.1 µM),
ascorbic acid phosphate (50 µM), and β-glycerophosphate (10 mM) (Sigma-Aldrich) (Sottile et al. 2002) ; (ii)
OS-FCS (osteogenic supplement only): recipe as stated in (i) but with no FCS. Cells (passage 37) were treated
with OS+FCS for 1, 2, 3, 4 and 5 days, before switching to OS-FCS for the remainder of the 21 day culture
period. Control wells were treated in parallel with OS+FCS or OS-FCS for the 21 days without switching. An
additional control culture was also treated with SC medium in the absence of osteogenic supplements for the
duration of the assay. A summary of the different culture conditions used is presented in figure 1a. The medium
was changed every day for the first 5 days of culture, after which the medium was changed every 3 days.
62.3. Chondrogenic differentiation
To determine the influence of serum exposure on the chondrogenic differentiation of hMSCs, two media were
tested, (i) CS-FCS (serum-free chondrogenic medium): DMEM supplemented with 1% (v/v) L-glutamine, 1%
(v/v) NEAA, 1 % penicillin/ streptomycin, dexamethasone (0.1 μM), ascorbic acid phosphate (50 µM), sodium-
pyruvate (1 mM), L-proline (40 µg/ ml), TGF-β (10 ng/ ml) and ITS+ (Sigma-Aldrich). (ii) CS+FCS 
(chondrogenic medium containing FCS): recipe as stated in (i) with the inclusion of 10% (v/v) foetal calf serum.
Cell pellets were formed with 2.5 x 105 cells (passage 39) and cultured in a polystyrene falcon tube as
previously described (Sottile et al., 2002). One set of pellets was treated with CS+FCS for 5 days and then
switched to CS for the remainder of the 21-day culture period (‘CS5‘), and another set was treated for the 21
days with CS+FCS medium (‘CS+FCS’). Pellets maintained for 21 days in CS-FCS medium (‘CS-FCS’) or SC
medium in the absence of all chondrogenic supplements (‘SC’) were used to provide positive and negative
controls, respectively. A summary of the different culture conditions used is presented in figure 1b. The medium
was changed every day for the first 5 days of culture, then every 3 days for the remainder of the 21-day period.
2.4. Alamar Blue
Cell metabolic activity was evaluated using an Alamar blue assay after 21 days culture. This assay is a non-
endpoint, non-toxic assay that measures mitochondrial metabolic activity. After the 21-day culture, the medium
was removed and the samples washed 3 times with PBS at ca. 37 °C. Five hundred microlitres of Alamar Blue
solution (AbD Serotec, UK) (1:10 Alamar Blue: warm Hanks Balanced Salt Solution (HBSS)) were added to
each well. Three empty wells were filled as blanks, and the plate incubated for 80 min at 37 °C, 5% CO2, then
wrapped in aluminium foil and put on a plate shaker for 10 min. A 100 µl extract from each sample well was
transferred to a 96-well plate in triplicate. Fluorescence was measured at 530/25 nm excitation, 590/35 nm
emission using a Bio-TEK FLx800 micro-plate fluorescence reader.
2.5. Hoechst 33258 DNA Assay
Cell proliferation was determined by assaying for total DNA content after the 21-day culture period. The
fluorochrome Hoechst 33258 (Sigma-Aldrich) binds cellular DNA resulting in enhanced fluorescence, which is
directly proportional to the DNA content (Rago et al., 1990). To lyse the cells, the culture medium was replaced
with 1ml sterile dH2O, and the well plate stored at -20 ºC. Once frozen, the well plate was placed into the
7incubator at 37 °C to thaw, and the cycle repeated 3 times. Aliquots of 100 µl from each well were transferred to
a 96-well plate, along with 100 µl Hoechst stain used at a working dilution of 1:50 in TNE buffer (10mM Tris
(hydroxymethyl)methylamine, 1mM EDTA and 2mM NaCl in distilled water, pH 7.4). The plate was gently
agitated and fluorescence measured at 360 nm excitation, 460 nm emission using a Bio-TEK FLx800 micro-
plate fluorescence reader. A standard curve of DNA was produced using known concentrations of DNA from
calf thymus (Sigma-Aldrich) reconstituted in 0.01M NaCl at a concentration of 20µg/ml.
2.6. DMMB assay
Binding of 1, 9-dimethylmethylene blue (DMMB) to sulphate and carboxylate groups was used to quantify
glycosaminoglycans (GAG) (Farndale et al., 1982). Briefly, samples were incubated with 1 mL papain solution
overnight in a waterbath at 60 °C (0.1% papain (Sigma-Aldrich) : papain buffer (sodium phosphate 0.1 M,
cysteine hydrochloride 0.005 M, EDTA 0.005 M and dH2O)). Papain-digested pellet samples were diluted 1:100
with heat-treated papain solution and aliquots of 20 µl were taken in triplicate from each well and transferred to
a 96 well-plate. A GAG reference calibration curve was generated using chondroitin-4-sulfate (Sigma-Aldrich)
and 20 µL DMMB solution were added to each well before optical density measurement at 540 nm (Bio-TEK
ELx800 micro-plate reader).
2.7. Safranin-O staining
After 21 days culture, the pellets were washed in PBS and fixed in 4 % PFA. After washing again in PBS, they
were submerged into 15% sucrose in PBS for several hours, and transferred to a 30 % sucrose solution and left
over night. Pellets were then embedded in an OCT compound (Tissue-Tek, USA) and frozen. Samples were
loaded into the cryostat and cut into sections 5 µm thick and collected on SuperFrost® glass slides (VWR).
Pellet sections were rinsed in PBS to remove OCT prior to being washed with dH2O and rehydrated through a
series of methanol (100% [v/v], 90 % [v/v] and 70 % [v/v]) and rinsed in tap water. Sections were then
incubated in Mayer’s hematoxylin for 5 minutes, rinsed under running water to blue nuclei and rinsed in dH2O.
Slides were then immersed into 0.1 % Safranin-O for 10 minutes and dehydrated through an increasing series of
methanol (70% [v/v], 90 % [v/v] and 100 % [v/v]. Sections were finally cleared in xylene and mounted using
DPX prior to viewing under a phase contrast microscope.
2.8. Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
8RT-PCR analysis was performed following protocols described elsewhere (Sottile et al., 2003), using the
following primer sequences (Eurofins MWG, Germany): bone/liver/kidney alkaline phosphatase (ALP): forward
‘gcagccactgagcgttc’ / reverse ‘gtgggagtgcttgtatctc’ ; osteocalcin (OCN): forward ‘ctcacactcctcgccctatt’ / reverse
‘aactcgtcacagtccggattg’ ; clathrin (CLATH): forward ‘ttataatgggggaaaacagg’ / reverse ‘ttgtctttgttggcactga’. In
brief, PCR reactions were heated at 95 ºC for 5min, before undergoing cycles of [95 ºC for 30 s, 60 ºC for 45 s
and 72 ºC for 1min] repeated 30 times for ALP and CLATH, and 38 times for OCN. Expression of each marker
gene was measured using the Aida Image Analyzer software and normalised against CLATH expression, used as
loading controls as previously described (Sottile et al., 2002, Sottile et al., 2003).
2.9. ELISA for osteocalcin
An osteocalcin ELISA kit (Invitrogen, UK) was used to measure intact osteocalcin concentrations following
manufacturer’s instructions. The absorbance of the samples (proportional to the human osteocalcin
concentration) was read at 450 nm using a colourmetric plate reader (Bio-TEK Elx800 micro-plate reader).
2.10. Immunohistochemistry
Cells were fixed in ice cold 4% PFA for 15 min and washed in PBT (PBS + 0.1% Tween20) for 5 min. Non-
specific binding was blocked by incubation with 0.75% FCS in PBT for 1 hour. Cells were then exposed to the
primary antibody (bone alkaline phosphatase and osteonectin antibodies from DSHB, osteocalcin antibody from
Abcam) at a dilution of 1:200 in PBT, and stored at 4 C overnight. After washing 3 times in PBT for 20 min
intervals, cells were incubated with a 1:200 dilution of Texas Red-conjugated secondary antibody (VectorLabs)
for 1 hour in the dark, before washing 4 times in PBS for 15 min per wash. Samples were finally mounted onto
microscope slides using Vectashield mounting medium containing dapi (VectorLabs), and analysed with
fluorescent light microscopy.
2.11. Alizarin red staining and quantification
After 21 days in culture, cells were fixed with 4% paraformaldehyde (PFA) for 15 min. After washing three
times with PBS, 1ml of 1% Alizarin red (aqueous) (Sigma-Aldrich) was added to each well and left for 10 min,
prior to multiple washes with dH2O (Tataria et al., 2006). Once the excess stain had been removed, bone
nodules were viewed using a phase contrast microscope. Quantitative analysis of alizarin red staining was
achieved by the extraction of the stain using a de-stain solution (Tataria et al., 2006) (20% methanol, 10% acetic
9acid in H2O) for 15 min, whilst the well plates were gently agitated using a plate shaker. Alizarin red
concentrations were determined using a colourmetric plate reader at a wavelength of 405 nm (Bio-TEK Elx800
micro-plate reader). Values obtained were normalized to DNA content/well.
2.12. ESEM and EDX –mineralisation identification and quantification
Cell cultures were washed 3 times with warm PBS and fixed in 3% glutaraldehyde in 0.1M cacodylate buffer for
30 min, then washed in 0.1M cacodylate buffer containing 7% sucrose. Cells were then viewed and analysed in
a Philips FEG Environmental SEM (ESEM), operated at 10kV, with field emission gun in wet mode, allowing
analysis to be carried out on un-processed samples. Resulting Energy-dispersive X-ray (EDX) spectra were used
to identify elements present as a result of matrix mineralisation.
2.13. FIB-TEM
FIB-SEM (for lift-out) and FIB-TEM (for evaluation) were carried out using protocols detailed elsewhere
(Edwards et al., 2009). In brief, prior to sectioning using an FEI Quanta 200 3D FIBSEM, samples were fixed in
ice-cold 4% PFA and dehydrated. A small strip of Cu conducting tape was put on the surface of the sample to
provide a conductive path from a region adjacent to the region to be milled and the sample support. Ion beam
induced deposition of W on the surface connected the Cu tape to the region to be milled, whilst a further W
deposition using a gas injection system provided a ~2 µm thick protective layer over the region to be sectioned.
A section was cut from the sample and transferred using an Omniprobe manipulator needle to a Cu TEM
support grid for final thinning using lowering current steps, finishing at 30kV and 30pA. Electron-transparent
specimens were then examined using STEM (Scanning Transmission Electron Microscopy) imaging and EDX
analysis, both carried out on a JEOL 2100F TEM.
2.14. Statistics
All experimental data represent mean ± SEM of two repeats of experiments, with 4 wells/pellets seeded for each
assay. Triplicates from each well were taken for quantitative assays. Statistical comparisons for all experimental
sets were based on one-way ANOVA using Tukey’s post-test for pair-wise comparisons with a p < 0.05
considered as significant unless otherwise stated.
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3. Results
3.1. Transient serum exposure supports MSC metabolic activity
To evaluate the effects of varying FCS exposure regimes on OS-treated MSC cultures (figure1a), we performed
a proliferation assay comparing the DNA content present in cultures (figure 2a). Proliferation was increased
with prolonged exposure to serum in the culture media. There was no significant difference between cells
maintained in SC medium, and OS0 cells that were not exposed to FCS. There was also no significant difference
in the DNA content from cultures OS1, OS2, OS3 and OS4. However, a significant increase was observed after 5
days exposure to FCS in the OS5 culture (p<0.05), which in turn showed no significant difference to OS21
(p>0.05). In addition, the metabolism in MSCs cultured under OS conditions with varying FCS exposure
periods was measured using the alamar blue assay (figure 2b). The development of fluorescence represented
increased metabolic activity, indicating the cells were healthy and viable for proliferation. Alamar blue
reduction increased with exposure to FCS, and was significantly higher in all conditions compared to the SC
conditions (p<0.001). No significant difference was detected between OS0, and the cultures exposed to FCS for
1, 2 and 3 days. There was a significant increase in metabolic rate after 4 days exposure, but no significant
difference was found for exposures longer than 4 days (p>0.05).Analysis of cell viability by propidium iodide
staining confirmed that MSCs were not adversely affected when exposed to FCS for 5 days compared to
standard FCS-containing OS treatment (Suppl. Fig.1).
3.2. Transient exposure to FCS supports expression of osteogenic markers
Expression of the osteogenic markers bone-specific alkaline phosphatase (ALP) and osteocalcin (OCN) was
analysed using RT-PCR (figure 3a). The expression of ALP was higher in all conditions containing OS
supplements compared to the SC control. Although there was no difference between OS0, OS1, OS2, exposure to
FCS for 4 days or more saw a significant increase of the ALP signal, with an expression level observed for 5-day
exposure to FCS comparable to that observed for OS21. OCN upregulation was also seen with increased
exposure to FCS. While no clear difference was seen between OS0 and 1-day exposure to FCS, both showing
low levels of OCN, a significant increase was seen after 4 days exposure to FCS with no substantial difference
between OS4, OS5, and OS21 conditions.
To confirm this result, the concentration of OCN protein present in selected cultures was quantified using
an ELISA assay (figure 3b). A significant increase in OCN concentrations was seen with increased exposure to
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FCS. There was no significant difference detected between 5 days exposure to FCS and OS21 (p>0.05).
Comparable to previous data, there was a significant difference between this and OS0 which was not exposed to
FCS (p<0.001), which in turn was expressing higher levels of OCN than the SC control. Trace amounts of OCN
protein were detected in the SC control.
Immunohistochemical staining was used to further assess presence of alkaline phosphatase (ALP),
osteocalcin (OCN) and osteonectin (OSN) in hMSC cultures (figure 3c). Staining was observed for all three
markers in conditions exposed to OS supplement, with a qualitative increase in expression with increased
exposure to FCS. A strong ALP, OCN and OSN signal was detected in OS5 and OS21. In comparison,
expression was much lower is conditions treated without FCS, but still higher than the SC control. Minimal
expression ALP and OCN expression was detected in the SC control.
3.3. Transient serum exposure supports mineral deposition
To further evaluate the effect of transient serum exposure on MSC differentiation, cultures were stained with
Alizarin red to analyse mineral deposition. The SC control showed only minimal background staining. In the
presence of OS supplements, nodular aggregates were visible in all conditions, indicating the presence of
calcium phosphate deposits resulting from a calcifying extra-cellular matrix (ECM) (figure 4). Quantification of
the Alizarin red staining in parallel cultures showed that there was no significant difference between OS0 and
OS1, OS2 and OS3 (p>0.05). However, a significant increase was seen after 4-day exposure to FCS (p<0.001),
and after a 5-day FCS exposure there was no significant difference compared to the OS21 positive control.
In order to better characterise the mineral deposited in the cultures, a more detailed microscopy analysis
was performed using ESEM (figure 5). All cells treated with OS, with and without serum, displayed an enlarged
stellate structure, characteristic of osteogenically differentiated MSCs compared to the SC control, which
retained the small, elongated fibroblastic shape typical of undifferentiated MSCs. All samples except the
negative control (SC) showed evidence of matrix mineralisation when analysed using ESEM (figure 5a). Two
distinct crystal phases of the mineral were present, one visually characteristic of crystalline HA (dendritic
structure), and the other of amorphous HA (spherical, globular structure). Further evaluation using EDX
analysis confirmed that the matrix was rich in calcium phosphate, giving Ca:P ratios ranging from 1.53 to 1.59
(figure 5b).
FIB-TEM was used to examine the composition of the ECM of the multilayered cell culture close to the
ThermanoxTM disc, to ensure that matrix mineralisation was taking place throughout the culture, and not just on
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the surface (figure 6). The four predominant elements detected by EDX mapping of the STEM section were
found to be carbon, calcium, oxygen and phosphorous. Carbon and oxygen were identified to spatially occupy
the same area, whilst calcium and phosphate were shown to be co-localised (figure 6b). The carbon and oxygen
signals are typical of general organic cellular matter. Trace amounts of oxygen were also detected in the same
regions as the calcium and phosphorus, suggesting regions of mineralised matrix.
3.4. Transient serum exposure is compatible with chondrogenic differentiation
To assess whether the short serum exposure used in the above described protocol would be compatible with
chondrogenesis, we performed a micromass pellet chondrogenesis assay. hMSCs were subjected to the
chondrogenesis protocol in standard serum-free conditions (CS), or following a 5-day transient serum exposure
(CS5). In both cases, hMSCs showed a similar level of chondrogenic response, as shown by the measurement of
GAG production (figure 7a) and by strong Safranin-O staining (figure 7b). In comparison, hMSC pellets treated
in the continuous presence of serum (CS21) failed to differentiate and remained negative, as was observed for
hMSCs maintained in control medium devoid of chondrogenic cues (SC).
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4. Discussion
In this study, we have investigated the effect of reduced exposure to foetal calf serum on the differentiation of
human mesenchymal stem cells. Although efficient differentiation was not achieved in the absence of serum
throughout the treatment, our findings demonstrate that it is possible to achieve osteogenic differentiation,
producing mineralising osteoblast-like cells, without FCS continuously present in the osteogenic culture
medium. These results support other studies suggesting that MSC cultures can be maintained in reduced serum
conditions (Gronthos and Simmons 1995; Kuznetsov et al., 1997). Although serum-free formulations for the
maintenance of MSC cultures are the subject of ongoing investigations (Sotiropoulou et al., 2006; Berger et al.,
2006), existing studies indicate that human bone marrow stromal cells (BMSC) demonstrated more rapid
proliferation in FCS-containing medium, while little proliferation occurred in serum-free conditions, suggesting
that the presence of high FCS was more effective than serum-free solutions (Kuznetsov et al., 2000). Results
from our cellular assays also showed that the efficacy of the cultures with regards to proliferation and
metabolism was greater in FCS-containing medium; however the use of a 5-day boost with FCS followed by
serum-free medium for the remaining culture period produced results with no significant difference compared to
FCS exposure for the full 21-day period. The metabolic activity and proliferation rates of the OS0 culture were
still higher than the SC control, but significantly lower than those exposed to OS21, in agreement with studies
showing that cells still proliferate without serum in the medium but often experience senescence, lowering the
overall proliferation rates (Agata et al., 2009).
With regards to osteogenic differentiation, the literature is unclear regarding serum-free treatments of
MSCs without the use of serum-replacements. Montzka et al. investigated the effect of reducing the serum
content of the osteogenic media to 2% from the standard 10%, and found osteogenic differentiation to be
successful without the need for additional growth factors to the culture media (Montzka et al., 2010). It
remained so far unclear whether temporally reducing exposure to serum would enable successful differentiation.
Our study indicates that with 5-day exposure to FCS, efficient differentiation is obtained, with no significant
difference for both mineralisation and osteogenic marker expression when compared to cultures with serum-
containing osteogenic medium for the complete 21-day period. This underlines the important role of FCS in the
initiation process, and indicates that differentiation is not solely dependent on osteogenic supplement (ascorbic
acid, dexamethasone and β-glycerophosphate).  
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Bone specific alkaline phosphatase plays a major role in bone calcification, specifically matrix
mineralisation and therefore its expression during osteogenic differentiation is considered to be a useful marker
of successful matrix mineralisation, indicating the presence of osteoblasts-like cells (Siffert, 1951). Alkaline
phosphatase expression was significantly lower in the serum-free conditions, and increased with exposure to
FCS, fitting closely with the data from cell proliferation and metabolism assays. Similar results produced by
Agata et al. show that ALP activity in serum-free expanded BMSC was significantly lower than that of BMSC
expanded with serum, regardless of the duration of the osteogenic induction (Agata et al., 2009). In combination
with the proliferation data from the current study, this suggests that OS0, OS1 and OS2 conditions may lead to
many cells remaining in an undifferentiated state within the culture, explaining the low levels of ALP produced.
Similar observations were reported when Friedman et al. found that lower ALP expression was seen in serum-
free conditions before the addition of extra growth factors such as BMP to the culture medium (Friedman et al.,
2006). During the late stages of osteogenic differentiation before the initiation of mineral deposition, ALP
expression peaks and is usually followed by an increase in the expression of OCN, which occurs concurrently
with matrix deposition and is therefore tightly associated with mineralisation (Lian et al., 1999). The trend
observed for OCN expression is similar to that seen for ALP expression, confirming that the production of
osteoblast-like cells is higher in the cultures exposed to FCS for longer, and that a 5-day boost gives statistically
similar data to OS21 culture conditions. This suggests that there may be many cells in an undifferentiated state
remaining in the conditions with minimal or no exposure to FCS.
Interestingly, it was previously reported that when bone marrow stromal cells pre-cultured in serum-
containing medium were trypsinised and treated with osteogenic supplement without FCS for 3 days before
transplantation, bone formation was sustained in vivo when compared to cultures treated with serum-free
medium throughout, suggesting that biphasic culture approaches for osteogenic stimulation would be compatible
with efficient differentiation in vivo (Kuznetsov et al., 2000). Our observations further indicate that both
proliferation rates and osteogenic differentiation can be maintained in vitro to levels similar to FCS-containing
conditions if the serum boost is exercised for 5 days before switching to serum-free conditions. Analysis of the
Ca2+ incorporation into the extracellular matrix with Alizarin red (Titorencu et al., 2007) confirmed that 5-days
FCS inclusion in the treatment successfully produced a heavily mineralised matrix made up of calcium
phosphate at the day21. It will be interesting to further evaluate whether a similar outcome can be achieved at
shorter time-points, such as day14, in order to further optimise the differentiation protocol. Although the
complete exclusion of FCS from OS treatment produced some calcium deposits, quantification showed that
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mineralisation was significantly lower, in agreement with data from RT-PCR, ELISA and immunostaining
suggesting that little mineralisation was achieved in the absence of any serum exposure. In addition to the
presence of calcium nodules confirmed by staining, ESEM revealed two different phases of the mineralised
matrix in MSC cultures: a visually crystalline phase with a sharp dendritic structure, and a globular non-
crystalline phase. The use of EDX confirmed that these nodules were made up of calcium phosphate with Ca:P
ratios were close to that of hydroxyapatite (~1.67), indicating that osteogenic differentiation and successful
matrix mineralisation had been achieved with transient serum treatment.
Furthermore, our results show that the inclusion of the 5-day phase of FCS exposure supports both
mineralisation and successful chondrogenic differentiation of hMSCs, indicating that temporal restriction can
overcome the negative impact of long-term serum use on chondrogenic cultures (Wang et al., 2010; Lee et al.,
2009; Malpeli et al., 2004). Further evaluation of this transient protocol will be useful to establish the effect of
short serum exposure on the levels and kinetics of chondrogenic matrix component synthesis such as collagen II
and X. The results presented here underline the benefit of developing new approaches involving transient
exposure regimes in order to support dual differentiation from a single cell source. Further improvements to this
approach will seek to address remaining issues related to the use of biological products such as serum, including
risks associated with possible pathogens including prions and viruses, as this will be critical for subsequent
translational applications (Liu et al., 2007).
These results provide the basis for the development of a cellularised scaffold from a single material, in a
single chamber, with the aim to create two distinct regions harbouring osteochondral and osteogenic lineages.
The identification of a culture regime compatible with both lineages allows the design of new tissue engineering
approaches, in which naive MSCs seeded on a scaffold and maintained in this biphasic culture medium can be
directed towards both osteogenic and chondrogenic fates by physical (such as graduated pore size) and
biochemical (such as growth factor release) cues provided locally within the scaffold. Such strategies combining
a united supportive differentiation medium and localised fate regulators can enable the production of single
scaffolds with gradual osteochondral properties through a natural interface, as seen in the osteochondral region
of a joint.
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5. Conclusions
In conclusion, we have identified a culture protocol that allows successful osteogenic differentiation of human
mesenchymal stem cells with osteogenic supplement but without the need for long term exposure to FCS. Our
data show that it is possible to treat the cells with osteogenic supplement and FCS for 5 days, and then remove
the serum, achieving a level of differentiation which is comparable to that observed in cells cultured in
osteogenic supplement with FCS for the full culture period. Our study also shows that this strategy of short term
serum treatment successfully maintains the chondrogenic potential of MSCs. These findings represent the first
step for the development of new culture approaches aiming to achieve the combined osteogenic and
chondrogenic differentiation of naive MSCs seeded in single scaffolds, in a single bioreactor, for joint repair.
This strategy can now be refined and integrated with other cues provided to the cells within the scaffold itself,
such as localised growth factor release or differential surface chemistry, in order to allow the biological
patterning of cellularised scaffolds for the repair of small skeletal defects.
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Figure Legends
Figure 1: Summary of the culture conditions used for the osteogenic (a) and chondrogenic (b) differentiation
assays carried out in the study, describing the sequential treatments with standard culture medium (SC), serum-
free osteogenic medium (OS-FCS), serum-containing osteogenic medium (OS+FCS), serum-free chondrogenic
medium (CS-FCS) and serum-containing chondrogenic medium (CS+FCS).
Figure 2: Analysis of growth kinetics in cultures maintained in the different experimental conditions over 21
days. (a) DNA content from cultures after variable exposure to OS+FCS over a 21-day period. Cell proliferation
was significantly higher with an increased exposure to OS+FCS. No significant difference was found between 5
and 21 days exposure to OS+FCS. Bars represent mean ± SEM (n=4). (b) Metabolic activity in cultures after
variable exposure to OS+FCS over a 21-day period. Alamar blue reduction increased with longer exposure to
OS+FCS. There was a significant increase after 4 days exposure but no significant difference thereafter. Bars
represent mean ± SEM (n=4). (*p<0.05, **p<0.001). Culture conditions tested as defined in Fig.1.
Figure 3: Analysis of osteogenic markers after variable exposure to OS+FCS for a 21-day period. (a) PCR
analysis of alkaline phosphatase (ALP) and osteocalcin (OCN) expression at day 21, using clathrin (CLATH) as
housekeeping gene control, shows upregulation with increased exposure to OS+FCS with no significant
difference detected between OS5 and OS21 conditions. (b) Osteocalcin protein quantification in cultures with
variable exposure to OS+FCS shows longer exposure to OS+FCS leads to higher OCN expression detectable in
the cell culture. No significant difference was detected between 4 days exposure to OS+FCS and 21 days
exposure to OS+FCS (*p<0.05). (c) Immunostaining for alkaline phosphatase (ALP), osteocalcin (OCN) and
osteonectin (OSN) expression (red) in MSCs with variable exposure to FCS, with dapi couterstain (blue).
Increase in expression of all osteoblastic markers was detected with an increased exposure to OS+FCS. Minimal
expression for ALP and OCN was detected in the standard control, with significant upregulation in cells treated
with OS+FCS. Bar = 60m. Culture conditions tested as defined in Fig.1.
Figure 4: Alizarin Red staining of calcium containing nodules present in the mineralised matrix laid down after
21 days in culture with variable exposure to OS+FCS. (a) Wells stained from all conditions except SC control
were positive for mineralisation with nodules clearly visible. (b) Micrographs of stained nodules show variances
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in the intensity of the staining, indicating an increase in mineralisation with prolonged exposure to OS+FCS. (c)
Quantification of calcium nodules present in mineralised matrix after 21 days culture. Alizarin red staining was
stronger with increased exposure to OS+FCS. There was a significant increase after 4 days exposure
(**p<0.001), but no significant difference there after (p>0.05). Bars represent mean ± SEM (n=4). Culture
conditions tested as defined in Fig.1.
Figure 5: ESEM analysis locating calcium phosphate depositions within the mineralised matrix after 21 days
culture in control medium (SC) or osteogenic medium with variable exposure to FCS (OS5, OS21, OS0). ESEM
images (a) show mineral deposition and a change in morphology typical of osteogenically differentiated MSCs.
Dendritic and globular mineral deposits visible in OS5, OS21, and OS0 cultures are typical structures of
crystalline and amorphous hydroxyapatite respectively. (b) EDX spectra and Ca/P ratios confirming the
presence of calcium and phosphate in the mineralised matrix after 21 days culture in with variable exposure to
OS+FCS. Culture conditions tested as defined in Fig.1.
Figure 6: FIB-TEM analysis of multilayered cell composition close to Thermanox TM disc, showing ECM
mineralisation throughout the layers after 21 days in culture. EDX of the STEM sample (a) identified 4
predominant elements (b): carbon, calcium, oxygen, phosphorus. Carbon and oxygen were detected in same
region, typically representing organic cell material, whilst calcium and phosphorus also co-localised, typically
containing trace amounts of oxygen, confirming the presence of a mineralised matrix.
Figure 7: Analysis of MSCs exposed to chondrogenic treatment for 21 days. (a) GAG quantification obtained
using the DMMB assay (n=3). (b) Safranin-O staining with hematoxylin counterstaining of sections from
micromass pellets grown in chondrogenic conditions with varying exposure to FCS. Bar = 140 µm. Culture
conditions tested as defined in Fig.1.
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Supplementary Material:
Suppl. methods:
Flow cytometry analysis of propidium iodide-stained cells:
MSCs were treated in 6-well plates and harvested at day 14 using trypsin/EDTA. After centrifugation 5min at
200g, cells were resuspended in propidium iodide (1g/ml in PBS), and kept in the dark until FACS analysis.
Duplicate biological samples were analysed using a Coulter Altra to measure 50000 events per tube. Culture
conditions tested as defined in Fig.1.
Figure legend:
Suppl. Figure 1: Flow cytometry analysis of propidium iodide-stained cells measured at day 14 showing fewer
necrotic cells in OS5 treatment than in OS21.
